Skip to content

Clinical trials

Completed Carcinoma, Non-Small-Cell Lung trials in Estonia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Completed Country / region: Estonia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20042
20131
20141
20151
20172
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Hoffmann-La Roche2
AbbVie1
AstraZeneca1
Cantargia AB1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Incyte Corporation1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung11
Carcinoma, Hepatocellular1
Carcinoma, Transitional Cell1
Colorectal Neoplasms1
Lung Neoplasms1
Neoplasm Metastasis1
Neoplasms1
Small Cell Lung Carcinoma1
Triple Negative Breast Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.